Key result
Myocardial CHK2 suppression using AAV9-TnT-CHK2shRNA enhanced post-MI cardiac function, attenuated fibrosis, and promoted endogenous cardiomyocyte proliferation in mice at 1 week.
Population
mTmG lineage tracing mice with myocardial infarction induced by mid-LAD ligation
Comparison
AAV9-TnT-CHK2shRNA injected 1-day… vs Sham or untreated myocardial infarction
Design
Preclinical
Follow-up
1 week
Authors
Loading...
Suppression of checkpoint kinase 2 (CHK2) in cardiomyocytes promotes endogenous proliferation and improves cardiac function and remodeling after myocardial infarction in a mouse model.
Suppression of checkpoint kinase 2 (CHK2) in cardiomyocytes promotes endogenous proliferation and improves cardiac function and remodeling after myocardial infarction in a mouse model.
Dai et al. (2025) studied Myocardial infarction. AAV9-TnT-CHK2shRNA vs. Sham or untreated post-MI was evaluated on Cardiac function, scar size, and cardiomyocyte proliferation. Myocardial CHK2 suppression using AAV9-TnT-CHK2shRNA enhanced post-MI cardiac function, attenuated fibrosis, and promoted endogenous cardiomyocyte proliferation in mice at 1 week.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: